{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-036342","form_type":"8-K","ticker":"YCBD","cik":"0001644903","company_name":"cbdMD, Inc.","filed_at":"2025-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.028019+00:00","generated_at":"2026-05-16T16:56:19.041534+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"cbdMD Q4 net sales up 3-5% YoY; FY net loss improves to ~$2M from $3.7M","bullets":["Net sales for fiscal 2025 expected $19.1–19.3M vs $19.5M prior year.","Q4 net sales expected $4.7–4.9M, up 3-5% from $4.6M in Q4 2024.","Net loss for fiscal 2025 improved to $1.9–2.1M from $3.7M in fiscal 2024.","CEO cites disciplined cost management and positive sequential revenue growth.","Full earnings call scheduled for mid-December 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-036342","json":"https://secwatch.observer/filing/0001437749-25-036342.json","markdown":"https://secwatch.observer/filing/0001437749-25-036342.md","text":"https://secwatch.observer/filing/0001437749-25-036342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925036342/0001437749-25-036342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925036342/ycbd20251120_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:56:19.041534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}